Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc., 30343 [2016-11394]
Download as PDF
<![CDATA[
30343
Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
By order of the Commission.
Issued: May 11, 2016.
Lisa R. Barton,
Secretary to the Commission.
The company plans to manufacture
reference standards for distribution to
its research and forensics customers. In
reference to drug codes 7360
(marihuana) and 7370 (THC) the
company plans to manufacture these
drugs as synthetic. No other activities
for these drug codes are authorized for
this registration.
[FR Doc. 2016–11448 Filed 5–13–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Organix, Inc.
Notice of registration.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
VerDate Sep<11>2014
18:48 May 13, 2016
Jkt 238001
I
I
I
I
I
I
II
II
Controlled substance
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Nabilone (7379) ............................
Hydrocodone (9193) .....................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Schedule
II
II
II
II
II
II
II
[Docket No. DEA–392]
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to its customers.
Manufacturer of Controlled
Substances Registration: Johnson
Matthey Pharmaceutical Materials, Inc.
Dated: May 9, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–11393 Filed 5–13–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Organix, Inc. applied to be
registered as a manufacturer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Organix, Inc. registration
as a manufacturer of those controlled
substances.
SUPPLEMENTARY INFORMATION: By notice
dated November 27, 2015, and
published in the Federal Register on
December 3, 2015, 80 FR 75691,
Organix, Inc., 240 Salem Street,
Woburn, Massachusetts 01801 applied
to be registered as a manufacturer of
certain basic classes of controlled
substances. No comments or objections
were submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Organix, Inc. to
SUMMARY:
Gamma
Hydroxybutyric
Acid
(2010).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Heroin (9200) ...............................
Lysergic acid diethylamide (7315)
Morphine (9300) ...........................
Schedule
Dated: May 9, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Drug Enforcement Administration
ACTION:
Controlled substance
published in the Federal Register on
December 8, 2015, 80 FR 76311,
Johnson Matthey Pharmaceutical
Materials, Inc., 25 Patton Road, Devens,
Massachusetts 01434 applied to be
registered as a manufacturer of certain
basic classes of controlled substances.
No comments or objections were
submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Johnson Matthey
Pharmaceutical Materials, Inc. to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug Enforcement Administration
ACTION:
[FR Doc. 2016–11394 Filed 5–13–16; 8:45 am]
Notice of registration.
BILLING CODE 4410–09–P
Johnson Matthey
Pharmaceutical Materials, Inc. applied
to be registered as a manufacturer of
certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Johnson
Matthey Pharmaceutical Materials, Inc.
registration as a manufacturer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated November 30, 2015, and
SUMMARY:
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Siegfried USA, LLC
ACTION:
E:\FR\FM\16MYN1.SGM
Notice of registration.
16MYN1
]]>Agencies
[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Page 30343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11394]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Johnson Matthey Pharmaceutical Materials, Inc. applied to be
registered as a manufacturer of certain basic classes of controlled
substances. The Drug Enforcement Administration (DEA) grants Johnson
Matthey Pharmaceutical Materials, Inc. registration as a manufacturer
of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated November 30, 2015, and
published in the Federal Register on December 8, 2015, 80 FR 76311,
Johnson Matthey Pharmaceutical Materials, Inc., 25 Patton Road, Devens,
Massachusetts 01434 applied to be registered as a manufacturer of
certain basic classes of controlled substances. No comments or
objections were submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of Johnson Matthey Pharmaceutical
Materials, Inc. to manufacture the basic classes of controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security systems, verifying the
company's compliance with state and local laws, and reviewing the
company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Nabilone (7379)............................ II
Hydrocodone (9193)......................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to its
customers.
Dated: May 9, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-11394 Filed 5-13-16; 8:45 am]
BILLING CODE 4410-09-P
